Home » Abbott to Split Into Drug, Medical Device Manufacturers

Abbott to Split Into Drug, Medical Device Manufacturers

October 20, 2011

ABBOTT PARK, IL-Abbott Laboratories will split into two companies: One will focus on prescription drugs, the other will focus on medical device manufacturing. MORE

I want to hear from you. Tell me how we can improve.

BNP Media Owner & Co-CEO, Tagg Henderson

Tesla Wants to Start Building a New US Vehicle Plant This Summer

Thomas Survey: Two-Thirds of Manufacturers Likely to Reshore as a Result of Pandemic

What’s New With Cordless Tools

Manufacturers Shift to PPE Production to Fight COVID-19 Pandemic

Tesla Workers at California Plant Test Positive for COVID-19

Events

June 25, 2020

Best Practices for Designing Modern Control Panels

This webinar will provide industrial controls engineers insightful and actionable information on how to best design control panels for modern manufacturing environments. The thought-leadership style of the content will offer a credible viewpoint on how to transform plant floors and machine designs for an era of rapidly increasing data capture.

October 27, 2020

The ASSEMBLY Show

The ASSEMBLY Show focuses exclusively on assembly technology equipment and products. Attendees have the opportunity to uncover new resources, experience equipment hands-on, evaluate the latest technologies and products, and connect face-to-face with industry experts.

View All Submit An Event

Poll

Supply Chain

The coronavirus epidemic has begun to disrupt the global manufacturing supply chain for a number of OEMs, including Airbus, Hyundai and Tesla. How resilient is your supply chain network?

Moderately resilient: We have good visibility to the supply network. It’s hard to justify investments to modify our supply chain footprint. We focus more on managing disruptions once they occur.

Highly resilient: We have good visibility to the supply network. We view flexibility and resilience as necessary investments. We can shift sourcing, manufacturing or distribution within our network fairly rapidly.

Not resilient: We are dependent on our existing sourcing, manufacturing and distribution footprint. We must find other ways to compensate for changing conditions. We have yet to invest in analytics to support network decision making.

View Results Poll Archive

Products

Manufacturing Cost Policy Deployment (MCPD) Profitability Scenarios: Systematic and Systemic Improvement of Manufacturing Costs

See More Products

Assembly Magazine

2020 June

The 2020 June Assembly features our cover story: High-Speed Rail Demands Light Railcars, plus much more. Check it out today!

View More Create Account

Design, CMS, Hosting & Web Development :: ePublishing

Abbott to Split Into Drug, Medical Device Manufacturers

Related Articles